The Pharmacokinetic Divide: CJC-1295 DAC vs. No DAC
In the landscape of Growth Hormone Releasing Hormone (GHRH) analogues, the distinction between CJC-1295 with DAC and CJC-1295 No DAC (often confusingly sold as Mod GRF 1-29) represents one of the most critical structural and clinical bifurcations. Understanding the DAC modification is mandatory for constructing a safe and effective GH secretagogue protocol.
Both compounds are synthetic, tetrasubstituted analogues of the first 29 amino acids of endogenous GHRH. Their primary function is identical: they bind to GHRH receptors on the anterior pituitary to stimulate the synthesis and release of Growth Hormone (GH).
However, their pharmacokinetic behavior—specifically their half-life and the resulting pattern of GH release—could not be more different. This divergence dictates their respective clinical applications, dosing schedules, and side effect profiles.
What is the DAC Modification?
DAC stands for Drug Affinity Complex. It is a crucial biochemical modification wherein a reactive maleimidopropionic acid (MPA) group is attached to the peptide chain.
• The Albumin Binding Mechanism: Upon injection, the MPA group immediately and covalently binds to endogenous serum albumin in the bloodstream.
• Biochemical Shielding: Because serum albumin is a massive, long-lasting transport protein, the bound CJC-1295 is shielded from enzymatic degradation (specifically by DPP-4) and renal clearance.
• The Half-Life Extension: While native GHRH has a half-life measured in minutes, the DAC modification extends the functional half-life of CJC-1295 to approximately 5 to 8 days. This is a monumental pharmacokinetic shift.

CJC-1295 No DAC (Mod GRF 1-29): Physiological Pulsatility
CJC-1295 No DAC lacks the maleimidopropionic acid group. Biologically, it is essentially modified GRF 1-29 (tetrasubstituted to resist rapid cleavage), giving it a half-life of roughly 30 minutes.
• Physiological Mimicry: Because of its short half-life, an injection of No DAC induces an immediate, sharp, and transient spike in Growth Hormone release that closely mimics a healthy, natural GH pulse.
• Receptor Recovery: By rapidly clearing from the system, it allows the pituitary GHRH receptors to reset. This preserves insulin sensitivity and avoids downregulation (desensitization) of the receptors.
• Clinical Application: It is widely considered the superior choice for long-term anti-aging, fat loss, and recovery protocols. However, it requires multiple daily injections (often stacked with Ipamorelin) to achieve maximum benefit.
CJC-1295 with DAC: Continuous GH Bleed
Because the DAC version remains active in the bloodstream for over a week, it continually agonizes the pituitary GHRH receptors, resulting in what endocrinologists refer to as a GH bleed.
• The Benefit: It requires highly infrequent injections (typically once or twice a week) while maintaining consistently elevated baseline levels of GH and IGF-1.
• The Risk Profile: The human body is entirely unaccustomed to continuous, non-pulsatile GH elevation. This sustained receptor activation mimics the pathological state of acromegaly or exogenous GH abuse more closely than physiological optimization.
• Adverse Consequences: The continuous "bleed" frequently leads to rapid receptor desensitization, severe water retention, joint pain (arthralgia), and clinically significant insulin resistance resulting in elevated fasting blood glucose.
Which Version Should You Choose?
For the overwhelming majority of clinical anti-aging, body composition, and regenerative medicine protocols, CJC-1295 No DAC is the definitive standard.
• No DAC preserves the vital pulsatile nature of GH release, safeguarding insulin sensitivity and preventing pituitary burnout. It is the preferred partner for stacking with a GHRP like Ipamorelin.
• With DAC offers extreme convenience but carries a substantially heavier burden of adverse metabolic side effects. Its use is generally reserved for highly advanced, short-term research contexts where a constant elevation in IGF-1 is prioritized over physiological homeostasis.
Final Word
⚕️ Medical Disclaimer: This article is for educational and informational purposes only. It does not constitute medical advice. Consult a qualified healthcare provider before using any peptide.